BioengineeringbioRxivPreprint
Engineered Flt3L Drives Tolerogenic State to Attenuate Anti-drug Antibody Responses
Aaron T. Alpar, Rachel P. Wallace, Kirsten C. Refvik…·Jeffrey A. Hubbell
The paper describes a method using engineered Flt3L to induce a tolerogenic immune state, reducing anti-drug antibodies to a fungal enzyme.
DOI 10.1101/2024.03.21.586168